New spectrum of COVID-19 manifestations in children: Kawasaki-like syndrome and hyperinflammatory response.
Where this comes from
- Record sourced from PubMed, PMID 32493734.
- Also identified by DOI 10.3949/ccjm.87a.ccc039.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
In April 2020, data began emerging on Kawasaki-like syndrome and hyperinflammatory response in children with COVID-19. Since then, much has been published on the presentation of COVID-19 in pediatric patients, including its association with Kawasaki disease and the multisystem inflammatory syndrome in children (MIS-C). However, questions still remain regarding the risk factors, pathogenesis, prognosis, and specific therapy for these manifestations of COVID-19.